VEGFA and renal cell carcinoma: Molecular targets, such as vascular endothelial growth factor (VEGF) or mTOR kinase, have been selected for newer therapeutics to improve the therapeutic index [6–9] and are recommended as the main treatments for advanced RCC [10, 11].